Vanguard Group
LPDX

Vanguard Group’s LIPOSCIENCE INC COM LPDX Stock Holding History

Vanguard Group’s Portfolio LPDX Stock Details LPDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-246,820
Closed -$1.28M – 4069
2014
Q3 		$1.28M Buy
246,820
+28,940
+13% +$94.5K ﹤0.01% 3435
2014
Q2 		$745K Hold
217,880
– – ﹤0.01% 3569
2014
Q1 		$695K Buy
217,880
+111,886
+106% +$470K ﹤0.01% 3565
2013
Q4 		$450K Buy
105,994
+33,648
+47% +$148K ﹤0.01% 3622
2013
Q3 		$362K Sell
72,346
-78,790
-52% -$441K ﹤0.01% 3605
2013
Q2 		$1.06M Buy
+151,136
New +$1.15M ﹤0.01% 3296

Vanguard Group's LPDX Position: Q4 2014 in Review

Vanguard Group sold out of LIPOSCIENCE INC COM (LPDX) in Q4 2014, closing a stake of 246,820 shares — an estimated $1.28M sold.

Vanguard Group first reported a position in LPDX in Q2 2013 and held it in 6 quarters. The position peaked at $1.28M in Q3 2014. 0 funds tracked by Wall St. Rank hold LPDX as of Q4 2014.

  • Vanguard Group reported no remaining LIPOSCIENCE INC COM position as of Q4 2014 after selling out during the quarter.
  • Vanguard Group sold 246,820 LIPOSCIENCE INC COM shares in Q4 2014, an estimated $1.28M.
  • Vanguard Group first reported a position in LIPOSCIENCE INC COM in Q2 2013 and held it in 6 quarters.
  • Vanguard Group's LIPOSCIENCE INC COM position peaked at $1.28M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held LIPOSCIENCE INC COM as of Q4 2014.

Based on Vanguard Group's 13F filing for Q4 2014, filed 12 Feb 2015.